We describe a 60-year-old man who presented with rectal pain and bleeding of a month's duration. His presentation was highly suggestive of lymphogranuloma venereum (LGV) proctitis. Nucleic acid amplification for chlamydia and gonorrhea via rectal swab revealed evidence supportive of anorectal chlamydia. Treatment with doxycycline resulted in complete resolution of his symptoms. P roctitis is defi ned as an infl ammatory syndrome of the distal 10 to 12 cm of the anal canal ( 1 ) . Etiologies of proctitis include infl ammatory bowel disease (IBD), radiation, diversion colitis, ischemia, and infection. Infectious causes can be further expanded to include sexually transmitted illnesses (STIs) such as gonorrhea, chlamydia, lymphogranuloma venereum (LGV), herpes simplex virus (HSV), HIV, and syphilis. STI-related proctitis, especially LGV-related proctitis, has been increasing in prevalence due to physician unawareness and poor screening protocols, and outbreaks have been discovered in both Europe and North America among men who have sex with men (MSM) ( 2, 3 ) .
LGV should remain in the diff erential in the MSM population with suspected chronic IBD because of the overlap in clinical presentation and histopathological diagnosis ( 4 ) . Early diagnosis is imperative, as delayed treatment can lead to irreversible sequelae.
CASE REPORT
A 60-year-old man presented with a complaint of hematochezia and rectal bleeding for 1 month. Th e stools occurred two to three times per day with associated symptoms of abdominal pain, bloating, constipation, loose stools, and rectal pain. He denied a history of Crohn's disease or ulcerative colitis. Th ere was no recent travel and no family history of gastrointestinal disease.
Th e patient's past medical history was signifi cant for wellcontrolled HIV, pulmonary embolism, depression, chronic weight loss, chronic pain, and insomnia. Th e patient was sexually active with an HIV-positive partner and participated in receptive anal intercourse. Medications included lamivudine/ zidovudine, warfarin, duloxetine, aripiprazole, hydrocodone/ acetaminophen, vitamin D, zolpidem, and merino. He was allergic to sulfonamides. 
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Tucker Harrison , DO, Mo Som , DO, MS, and Jeff Stroup, PharmD, BCPS His temperature was 97.9°F; heart rate, 92 beats per minute; blood pressure, 116/80 mm Hg; respiratory rate, 16 breaths per minute; and body mass index, 21 kg/m 2 . Blood was present in the feces. Th e remainder of the examination was normal. Laboratory results from 3 months earlier showed a white blood cell count of 5.6 × 10 9 ; hemoglobin, 13.6 g/dL; hematocrit, 41.8%; platelets, 278 × 10 3 ; sodium, 142 mmol/L; potassium, 4.9 mmol/L; blood urea nitrogen, 10 mg/dL; creatinine, 0.94 mg/dL; aspartate transaminase, 31 U/L; alanine transaminase, 17 IU/L; and bilirubin, 0.2 mg/dL. HIV studies from 3 months prior showed a CD4 count of 1127 with an undetectable viral load. A repeat hemogram showed a white blood cell count of 7.3 × 10 9 per liter, platelet count of 234 × 10 9 per liter, hemoglobin of 14.1 g/dL, and hematocrit of 41.3%. Th e erythrocyte sedimentation rate was 74 mm/h.
A colonoscopy was completed 3 weeks after the patient's presenting offi ce visit. A rectal mass and two sigmoid sessile polyps measuring <6 cm each were detected. Th e remainder of the colon was normal. Th e sessile polyps were hyperplastic and the rectal mass revealed ulceration with numerous fragments of a necroinfl ammatory ulcer base. Th ere was also evidence of reactive atypia of the surrounding colonic mucosa without defi nitive evidence of dysplasia.
Sigmoidoscopy revealed the continued presence of a rectal ulcer. Clostridium diffi cile testing was negative. Th e microscopic examination of the four biopsies found acute cryptitis with crypt abscess formation. Diff use acute and chronic infl ammatory cell infi ltrate was present throughout the mucosa. Cytomegalovirus and HSV-1 and -2 testing were negative. Th e urine sample was negative for both diseases, but the rectal swab was positive for chlamydia and negative for gonorrhea. Th e patient was prescribed doxycycline 100 mg for 21 days for LGV proctitis. Th e symptoms had completely resolved following his antibiotic course. Follow-up sigmoidoscopy with biopsy performed 3 months after treatment showed a healing ulcer with return of normal microscopic architecture. Lymphogranuloma venereum proctitis October 2016
Th e patient's partner was seen for similar symptoms and also had severe proctitis with sparing of the remainder of the colon on endoscopy, with evidence of cryptitis and prominent ulceration. He was also treated with a 21-day course of doxycycline with complete resolution of his symptoms.
DISCUSSION
Chlamydia is one of the most common sexually acquired illnesses worldwide ( 5 ) . Chlamydia is an obligate intracellular gram-negative bacterium. Serovars L1, L2, and L3 are known to cause LGV, a subtype of genital ulcer disease. It is transmitted through unprotected vaginal, anal, or oral sexual contact ( 3 ) .
LGV can present in three stages. Th e fi rst stage is characterized by a painless ulcer at the site of inoculation. Hemorrhagic proctitis is the primary manifestation of infection after direct transmission in the MSM population. Th ese lesions typically heal within 1 week. Th e second stage involves extension to regional lymph nodes and occurs 2 to 6 weeks later. Th ose with primary involvement of the rectum may have deep iliac or perirectal node involvement, which may cause intraabdominal or retroperitoneal lymphadenopathy. Th e third stage involves destruction of surrounding tissues and is a result of chronic infl ammation. Untreated, LGV proctitis may result in perirectal abscess, fi stulas, strictures, and stenosis of the rectum, which can ultimately lead to chronic progressive lymphangitis with chronic edema and sclerosing fi brosis ( 3 ).
Based on clinical presentation, endoscopy is typically performed.
LGV shares several common characteristics with IBD including fi ndings of hyperemic, friable mucosa with multiple ulcers and erosions and granulation tissue in the rectum ( 4 ). Diagnosis of rectal LGV relies heavily on presentation and high clinical suspicion based on risk factors, including MSM and a sexual history suggestive of an STI. LGV in the MSM patient is associated with additional risk factors including using enemas, having sex at sex parties, using recreational drugs, having unprotected receptive anal intercourse, and having sex with HIV-positive partners and anonymous partners ( 6 ) .
Laboratory diagnosis for LGV includes culture and nucleic acid amplifi cation tests, followed by genotyping via polymerase chain reaction-based restriction fragment length polymorphism analysis and serologic testing. In the MSM population that reports anorectal intercourse, rectal chlamydia screening is indicated. Patients with proctoscopic fi ndings of proctitis should be treated until rectal chlamydia tests are available. If anorectal fi ndings do not confi rm chlamydia, treatment should be discontinued after a minimum of 7 days. If anorectal testing confi rms chlamydia, LGV testing should follow when available. If anorectal testing is positive for chlamydia, but LGV testing is unavailable, a full course of treatment should be administered with one of the following fi ndings: proctitis noted during proctoscopic examination, >10 white blood cells per high-power fi eld in the initial Gram-stained anorectal smear specimen, or HIV seropositivity ( 3 ) . In addition, the Centers for Disease Control and Prevention recommends that patients with a clinical syndrome consistent with LGV, including proctocolitis, be treated ( 8 ) .
Treatment should be off ered to all patients due to the longterm sequelae of untreated disease. Doxycycline 100 mg twice daily for 21 days is currently the preferred regimen. Patients should be followed until resolution of symptoms. In addition, it is recommended that all partners in the past 6 months be warned about possible infection. Individuals who have come into sexual contact with the patient within 4 weeks of the onset of the patient's symptoms, or the last 3 months if the patient was asymptomatic when LGV was detected, should be tested and initiated on treatment ( 3, 9 ) .
